Breaking News Instant updates and real-time market news.

BKH

Black Hills

$60.23

0.235 (0.39%)

, GGG

Graco

$46.02

0.025 (0.05%)

08:40
08/15/18
08/15
08:40
08/15/18
08:40

CFA Society of Minnesota to hold a conference

7th Annual Investor Conference will be held in Minneapolis, MN on August 14-15 with webcasted company presentations to begin on August 15 at 8:30 am; not all presentations may be webcasted. Webcast Link

BKH

Black Hills

$60.23

0.235 (0.39%)

GGG

Graco

$46.02

0.025 (0.05%)

CLFD

Clearfield

$13.05

0.35 (2.76%)

CYBE

Cyberoptics

$19.25

0.05 (0.26%)

CHRW

C.H. Robinson

$93.98

0.02 (0.02%)

DAKT

Daktronics

$8.43

0.02 (0.24%)

CBZ

CBIZ

$22.93

0.275 (1.21%)

DGII

Digi International

$12.95

-0.025 (-0.19%)

PII

Polaris Industries

$107.72

0.42 (0.39%)

ASV

ASV Holdings

$6.28

-0.27 (-4.12%)

ALE

Allete

$77.99

0.97 (1.26%)

DOC

Physicians Realty Trust

$16.83

0.22 (1.32%)

APOG

Apogee Enterprises

$49.74

0.55 (1.12%)

MOS

Mosaic

$30.63

0.25 (0.82%)

DCI

Donaldson

$47.69

0.88 (1.88%)

SRDX

Surmodics

$73.05

2.1 (2.96%)

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 26

    Aug

  • 06

    Sep

  • 06

    Sep

  • 29

    Oct

  • 06

    Nov

BKH Black Hills
$60.23

0.235 (0.39%)

02/07/18
JPMS
02/07/18
DOWNGRADE
Target $52
JPMS
Neutral
Black Hills downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Christopher Turnure downgraded Black Hills to Neutral and lowered his price target for the shares to $52 from $56. The analyst feels the stock is now fairly valued given the reset of management earnings expectations late last year as well as the earnings and balance sheet pressure from tax reform. Turnure thinks it will take the company time to execute on the new rate case plan and provide more earnings visibility beyond 2018.
07/12/18
BOFA
07/12/18
DOWNGRADE
BOFA
Underperform
Black Hills downgraded to Underperform from Neutral at BofA/Merrill
07/12/18
07/12/18
DOWNGRADE
Target $60

Underperform
Black Hills downgraded to Underperform on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Black Hills to Underperform from Neutral and raised its price target to $60 from $59. Analyst Julien Dumoulin-Smith said shares are trading at premium with limited near-term catalysts.
07/24/18
HOWW
07/24/18
INITIATION
Target $58
HOWW
Sector Perform
Black Hills initiated with a Sector Perform at Scotia Howard Weil
Scotia Howard Weil analyst Andrew Weisel reinstated Black Hills with a Sector Perform and $58.
GGG Graco
$46.02

0.025 (0.05%)

01/23/18
DBAB
01/23/18
UPGRADE
Target $55
DBAB
Buy
Graco upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Saree Boroditsky upgraded Graco to Buy and raised her price target for the shares to $55 from $45. The company is a "best-in-class industrial" that is well positioned to benefit from strength in the global industrial economy and an acceleration in capital investment, Boroditsky tells investors in a research note. The analyst notes her 2018 estimates are 18% above consensus after taking into account end market trends and tax reform.
04/12/18
DADA
04/12/18
INITIATION
Target $48
DADA
Neutral
Graco initiated with a Neutral at DA Davidson
DA Davidson analyst Matt Summerville initiated Graco with a Neutral rating and a price target of $48, citing the company's leverage to positive trends across its end markets that include construction, industrial, and automotive. Summerville also points to Graco's "best-in-class" profitability, history of strong returns, and free cash flow generation. The analyst sees shares as "appropriately valued" however, adding he does not anticipate any material upgrade in consensus earnings.
CLFD Clearfield
$13.05

0.35 (2.76%)

12/29/17
LSCM
12/29/17
NO CHANGE
LSCM
Adtran guidance a negative for Clearfield, says Lake Street
Lake Street analyst Jaeson Schmidt views Adtran's (ADTN) lowered Q4 outlook this morning as a net negative for Clearfield (CLFD). A muted spending environment could create headwinds for the company in the first half of fiscal 2018, Schmidt contends. He still likes Clearfield longer term and keeps a Buy rating on the shares.
04/27/18
LSCM
04/27/18
NO CHANGE
Target $14.5
LSCM
Buy
Clearfield price target lowered to $14.50 from $16 at Lake Street
Lake Street analyst Jaeson Schmidt lowered his price target for Clearfield to $14.50 but keeps a Buy rating on the shares. The "muted" spending environment is creating near-term headwinds, Schmidt tells investors in a post-earnings research note. The analyst continues to believe that showing growth at Tier 1 customers is key to driving the stock's multiple "significantly higher."
CYBE Cyberoptics
$19.25

0.05 (0.26%)

10/03/17
CHLM
10/03/17
NO CHANGE
Target $20
CHLM
Buy
Cyberoptics price target lowered to $20 from $25 at Craig-Hallum
Craig-Hallum analyst Greg Palm lowered his price target for Cyberoptics to $20 from $25 on valuation. The analyst says that the second consecutive guidance cut is another blow but he continues to see value given a rich and broad portfolio of technology. Palm reiterates a Buy rating on the shares.
07/26/18
LSCM
07/26/18
NO CHANGE
Target $21
LSCM
Buy
Cyberoptics price target raised to $21 after earnings at Lake Street
Lake Street analyst Jaeson Schmidt noted that CyberOptics reported better than expected earnings and revenue and he thinks the opportunity for the company's 3D MRS-enabled products remains strong. Following the report, he reiterated his Buy rating and raised his price target to $21 from $19 on Cyberoptics shares.
07/26/18
CHLM
07/26/18
NO CHANGE
Target $25
CHLM
Buy
Cyberoptics price target raised to $25 from $20 at Craig-Hallum
Craig-Hallum analyst Greg Palm raised his price target for Cyberoptics to $25 from $20, citing better Q2 results and overall bullish outlook. The analyst reiterates a Buy rating on the shares.
10/03/17
LSCM
10/03/17
NO CHANGE
Target $15
LSCM
Buy
Cyberoptics price target lowered to $15 from $27 at Lake Street
Lake Street analyst Jaeson Schmidt lowered his price target on CyberOptics to $15 from $27 after the company cut its revenue guidance, saying this year will now represent a "meaningful step back" in growth, largely due to pushouts and lower than expected orders from SQ3000. However, he still sees CyberOptics with an opportunity to drive long-term growth with its MRS products and he keeps a Buy rating on the shares.
CHRW C.H. Robinson
$93.98

0.02 (0.02%)

08/02/18
KEYB
08/02/18
NO CHANGE
Target $105
KEYB
Overweight
C.H. Robinson price target raised to $105 from $100 at KeyBanc
KeyBanc analyst Todd Fowler raised his price target for C.H. Robinson to $105 from $100 to reflect Q2 upside and an improved Global Forwarding outlook, as well as expectations for normalizing net revenue margins going forward. The analyst continues to expect a cyclical recovery in net revenue margins, which, when combined with more closely managed operating expenses, may enhance operating leverage with intermediate-term earnings power of $5.50-$6.50. The analyst reiterates an Overweight rating on the shares.
07/13/18
07/13/18
UPGRADE

Positive
C.H. Robinson upgraded to Positive on low expectations at Susquehanna
As previously reported, Susquehanna upgraded C.H. Robinson to Positive from Neutral and raised its price target to $100 from $96. Analyst Bascome Majors sees upside to consensus earnings estimates for Q2, 2H 2018, and 2019 after expectations were reduced following the disappointing Q1. Majors views C.H. Robinson shares as attractive heading into the middle/later part of the truckload rate cycle given its contract-heavy truck brokerage model and believes the company is farther along in its own digital transformation than investors perceive.
07/13/18
SUSQ
07/13/18
UPGRADE
SUSQ
Positive
C.H. Robinson upgraded to Positive from Neutral at Susquehanna
08/09/18
08/09/18
DOWNGRADE
Target $101

Neutral
C.H. Robinson downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Ken Hoexter downgraded C.H. Robinson Neutral from Buy citing valuation and maintained a $101 price target.
DAKT Daktronics
$8.43

0.02 (0.24%)

01/24/18
SIDC
01/24/18
INITIATION
Target $10
SIDC
Neutral
Daktronics initiated with a Neutral at Sidoti
Sidoti started Daktronics with a Neutral rating and $10 price target.
CBZ CBIZ
$22.93

0.275 (1.21%)

06/12/18
SIDC
06/12/18
INITIATION
Target $26
SIDC
Buy
CBIZ re-initiated with a Buy at Sidoti
Sidoti re-initiated coverage of CBIZ with a Buy rating and $26 price target.
DGII Digi International
$12.95

-0.025 (-0.19%)

07/27/18
LSCM
07/27/18
NO CHANGE
Target $16
LSCM
Buy
Digi International price target raised to $16 from $14 at Lake Street
Lake Street analyst Jaeson Schmidt raised his price target for Digi International to $16 saying the company reported a "solid" quarter and revenue outlook with Internet of Things continuing to ramp. The analyst reiterates a Buy rating on the shares.
06/20/18
ADAM
06/20/18
NO CHANGE
Target $18
ADAM
Buy
Digi International price target raised to $18 from $15 at Canaccord
Canaccord analyst T. Michael Walkley raised his price target on Digi International to $18 from $15 following meetings with management. The analyst said the meeting focused on the cold chain monitoring market opportunity and he believes Digi has the team and solution sets to emerge as a leader in the fragmented market. Walkley reiterated his Buy rating on Digi International shares.
02/02/18
ROTH
02/02/18
INITIATION
Target $15
ROTH
Buy
Digi International initiated with a Buy at Roth Capital
Roth Capital analyst Scott Searle started Digi International with a Buy rating and $15 target, stating that the company is consolidating a leadership position in the "highly fragmented and ultimately multi-billion dollar" cold chain market.
07/05/18
FANA
07/05/18
NO CHANGE
Target $16
FANA
Overweight
Digi International target raised to $16 after CFO call at First Analysis
First Analysis analyst David Gearhart raised his price target for Digi International to $16 from $15 following a call with new CFO Gokul Hemmady. The analyst came away with greater confidence that management will execute on its end-to-end solutions strategy and be able to return the core hardware business to "sustained growth while maintaining solid profitability, driving above-market share returns." Gearhart reiterates an Overweight rating on Digi shares.
PII Polaris Industries
$107.72

0.42 (0.39%)

07/05/18
LBOW
07/05/18
NO CHANGE
LBOW
Neutral
Harley checks point to mid-single digit U.S. retail drop in Q2, says Longbow
Longbow analyst David MacGregor said his checks point to Harley-Davidson's (HOG) U.S. retail sales being down by a mid-single digits percentage in Q2. He now estimates Q2 U.S. shipments trending down 12-14%, which is a little worse than his previous expectation of down 11-13%. MacGregor, who believes Polaris Industries' (PII) Indian motorcycle gained market share from Harley in all segments, keeps a Neutral rating on Harley-Davidson shares.
06/18/18
RHCO
06/18/18
NO CHANGE
Target $132
RHCO
Hold
Polaris Industries price target raised to $132 from $125 at SunTrust
SunTrust analyst Michael Swartz raised his price target on Polaris Industries to $132 and kept his Hold rating, citing the impact from the company's recently announced Boat Holdings acquisition as well as the adjustment from the non-cash amortization charges of previous acquisitions. The analyst believes that Polaris Industries is a quality longer-term holding, but 2018 will likely be challenged by product recalls and end-market softness.
07/26/18
WELS
07/26/18
NO CHANGE
Target $125
WELS
Outperform
Polaris Industries price target lowered to $125 from $132 at Wells Fargo
Wells Fargo analyst Timothy Conder lowered his price target for Polaris Industries to $125 from $132 after shares slid post Q2 report with concerns over tariffs, channel inventories, and motorcycles. While the analyst believes inventory concerns are overdone, he argues that tariff uncertainty including potential incremental costs into 2019 is the primary concern. He reiterates an Outperform rating on the shares.
07/26/18
RHCO
07/26/18
NO CHANGE
Target $115
RHCO
Hold
Polaris Industries price target lowered to $115 from $132 at SunTrust
SunTrust analyst Michael Swartz lowered his price target on Polaris Industries to $115 and kept his Hold rating after its Q2 results, saying that despite the earnings and revenue beat, the 8% decline in the stock price was due to gross margin pressure and reduced motorcycle revenue. The analyst adds that while the retail off-road vehicle trends are still positive, he expects investor concerns motorcycles, inventory, and margin pressure to linger. as overhangs on the stock price.
ASV ASV Holdings
$6.28

-0.27 (-4.12%)

08/13/18
BRRR
08/13/18
NO CHANGE
Target $9
BRRR
Outperform
ASV Holdings price target lowered to $9 from $11 at Barrington
Barrington analyst Chris Howe lowered his price target for ASV Holdings (ASV) to $9 following the company's weaker than expected Q2 results. The quarter was impacted by a decline in undercarriage sales to Caterpillar (CAT) and increased input costs from the steel tariff, Howe tells investors in a post-earnings research note. The analyst, however, keeps an Outperform rating on ASV Holdings. He believes the company's revenue growth will pick up as its dealer network matures and turns over inventory at a faster rate.
11/21/17
BRRR
11/21/17
INITIATION
Target $11.25
BRRR
Outperform
ASV Holdings initiated with an Outperform at Barrington
Barrington analyst Matthew Gall started ASV Holdings with an Outperform rating and $11.25 price target. The company's Posi-Track undercarriage system, which involves a rubber tracked undercarriage instead of traditional steel tracks, provides a competitive differentiator, the analyst contends.
ALE Allete
$77.99

0.97 (1.26%)

02/13/18
WELS
02/13/18
NO CHANGE
Target $71
WELS
Market Perform
Allete price target lowered to $71 from $81 at Wells Fargo
Wells Fargo analyst Sarah Akers lowered her price target for Allete to $71 from $81 ahead of year-end results reflecting tax reform updates and other developments/adjustments. The analyst reiterates a Market Perform rating on the shares.
05/07/18
MZHO
05/07/18
DOWNGRADE
Target $75.5
MZHO
Neutral
Allete downgraded to Neutral from Buy at Mizuho
Mizuho analyst Paul Fremont downgraded Allete to Neutral citing valuation with the shares at all-time highs. The analyst continues to see potential near-term catalysts, but does not expect his earnings estimates to change. He raised his price target for the shares to $75.50.
06/11/18
WILL
06/11/18
DOWNGRADE
WILL
Hold
Allete downgraded to Hold from Buy at Williams Capital
02/28/18
MZHO
02/28/18
INITIATION
Target $71.5
MZHO
Buy
Allete initiated with a Buy at Mizuho
Mizuho analyst Paul Femont initiated Allete with a Buy and $71.50 price target to reflect potential upside from several different areas in the unregulated business and from additional investment at ALLETE Clean Energy
DOC Physicians Realty Trust
$16.83

0.22 (1.32%)

08/03/18
SOCO
08/03/18
UPGRADE
SOCO
Overweight
Physicians Realty Trust upgraded to Overweight from Equalweight at Capital One
Capital One upgraded Physicians Realty Trust to Overweight from Equalweight citing recent share underperformance.
04/25/18
STFL
04/25/18
DOWNGRADE
Target $17
STFL
Hold
Physicians Realty Trust downgraded to Hold from Buy at Stifel
As previously reported, Stifel analyst Chad Vanacore downgraded Physicians Realty Trust to Hold from Buy on slower growth expectations, noting that rising interest rates coupled with compressing cap rates have increased costs of capital and compressed investment spreads for medical office building focused REITs. He lowered his price target on Healthcare Realty Trust shares to $17 from $18.
04/24/18
STFL
04/24/18
DOWNGRADE
STFL
Hold
Physicians Realty Trust downgraded to Hold from Buy at Stifel
12/14/17
HDLY
12/14/17
NO CHANGE
HDLY
Hilliard Lyons Top Ideas for Year-End 2017
Hilliard Lyons Research named its Top Ideas for Year-End 2017. They are: Pinnacle Financial (PNFP), Disney (DIS), J.M. Smucker (SJM), NextEra Energy (NEE), Zoetis (ZTS), Leggett & Platt (LEG), South Jersey Industries (SJI), Tanger Factory (SKT), Physicians Realty Trust (DOC), VMware (VMW), AT&T (T), and American Water (AWK).
APOG Apogee Enterprises
$49.74

0.55 (1.12%)

04/13/18
DADA
04/13/18
NO CHANGE
Target $47
DADA
Buy
Apogee Enterprises price target lowered to $47 at DA Davidson
DA Davidson analyst Brent Thielman lowered his price target on Apogee Enterprises to $47 from $50 but kept his Buy rating, saying the shortfall in guidance and margin outlook as part of yesterday's earnings announcement was mostly related to the acquired EFCO side of the business. The analyst adds that the company's ROC remains "respectable" while the low end of guidance still implies 10% EBITDA growth and 6% earnings growth. Thielman also points to market growth, strong balance sheet, and low street expectations as positives for Apogee.
04/13/18
CHLM
04/13/18
NO CHANGE
Target $55
CHLM
Buy
Apogee Enterprises price target lowered to $55 from $60 at Craig-Hallum
Craig-Hallum analyst Eric Stine lowered his price target on Apogee Enterprises to $55 from $60 following the company's "mixed" Q4 results. In a research note to investors, Stine said he believes the company's outlook is "intact" despite lower guidance for fiscal 2019, due primarily to EFCO, which he said is likely to turn out to be a "good" acquisition strategically and that the new management put in place earlier this year should help improve performance going forward. However, Stine contended that these factors will have little impact on the "problem projects" already in its backlog. Stine, who has a Buy rating on Apogee shares, said investors "should not let EFCO distract" from positive trends across most of Apogee's businesses.
06/29/18
DADA
06/29/18
DOWNGRADE
Target $52
DADA
Neutral
Apogee Enterprises downgraded to Neutral at DA Davidson on valuation
As reported earlier, DA Davidson analyst Brent Thielman downgraded Apogee Enterprises to Neutral from Buy but raised his price target to $52 from $47 after the company's Q1 earnings beat and raised FY19 EPS outlook. Thielman points to diminished EFCO execution risk and improving prospects for the company's glass business, stating that segment margins have started to recover as problem contracts are being addressed. The analyst also notes positive backlog and order trend revealed in the latest earnings, but adds that the subsequent 13% rally in the stock price takes valuation to levels where risk-reward is more balanced.
06/29/18
DADA
06/29/18
DOWNGRADE
DADA
Neutral
Apogee Enterprises downgraded to Neutral from Buy at DA Davidson
MOS Mosaic
$30.63

0.25 (0.82%)

08/10/18
STPT
08/10/18
DOWNGRADE
STPT
Hold
Mosaic downgraded to Hold from Buy at Standpoint Research
07/24/18
07/24/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MOSAIC DOUBLE UPGRADED: BofA Merrill Lynch double upgraded Mosaic (MOS) to Buy from Underperform and raised its price target to $35 from $24. Analyst Steve Byrne said he believes 2018 will mark a bottom in global phosphate utilization rates and now believes there is more upside risk to consensus estimates as the cycle improves. Mosiac was higher by 3.5% approaching midday. BTIG SAYS BUY LIVE NATION: BTIG analyst Brandon Ross upgraded Live Nation (LYV) to Buy from Neutral with a $60 price target, saying he is now more convinced that the company will outperform expectations amid inflecting growth with an added possibility of M&A. Despite the tough comparisons, Ross notes that Live Nation should "handily" top operating income consensus in FY18 and going forward, having built an "insurmountable" competitive float in U.S. markets, and that its mid-teens EBITDA growth is "the new normal". WHIRLPOOL CUT AFTER EARNINGS: Longbow analyst David MacGregor downgraded Whirlpool (WHR) to Neutral from Buy after the company reported Q2 earnings that missed the firm's "Street low" estimate of $3.55, calling its quarter "disappointing across most dimensions of the business." Expectations for a recovery in the EMEA region are being pushed out to beyond 2020, noted MacGregor, who is waiting for after the company's earnings call to reassess his view of its earnings prospects. MIZUHO CALLS EOG 'THE APPLE OF OIL': Mizuho analyst Paul Sankey started EOG Resources (EOG) with a Buy rating and $173 price target, calling EOG -- his top pick in the group -- the Apple (AAPL) of oil. EOG has been a pioneer in unconventional oil development in the U.S. and its technology-driven, innovation-focused approach will continue to drive peer-leading rates of return and oil growth, the analyst contended. EOG was up 2.6% near midday. SUSQUEHANNA RAISES ALPHABET TARGET TO $1,500: After Alphabet's (GOOG, GOOGL) Q2 earnings report on Monday night, many analyst firms raised their price targets on the name. The highest of those targets was from Susquehanna analyst Shyam Patil, who raised his price target on Alphabet to $1,500 from $1,250. The analyst cited the "impressive" sites revenue growth acceleration, which he sees as evidence that the secular momentum for the ads business remains in place. Patil reiterated his Positive rating on Alphabet shares. Class A shares of Google's parent were up over 4% to $1,260.80 at time of writing.
07/24/18
07/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mosaic (MOS) double upgraded to Buy from Underperform at BofA/Merrill with analyst Steve Byrne saying he believes 2018 will mark a bottom in global phosphate utilization rates and now believes there is more upside risk to consensus estimates as the cycle improves. 2. Live Nation (LYV) upgraded to Buy from Neutral at BTIG with analyst Brandon Ross saying he is now more convinced that the company will outperform expectations amid inflecting growth rate with an added possibility of M&A. 3. Infinera (INFN) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux saying the calculus of his March downgrade changes with the acquisition of Coriant, giving the company a double-digit market share in 100G+ optical systems. 4. Baker Hughes (BHGE) upgraded to Buy from Hold at SunTrust with analyst Ken Sill saying the EPS miss was due to higher interest expense and taxes, as well as an asset charge that is "hopefully non-recurring." 5. Werner (WERN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ken Hoexter saying Q2 freight demand in One way Truckload was much stronger than normal and revenue per load mile was up 13.3% year-over-year, the strongest level in more than 20 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/18
07/24/18
UPGRADE
Target $35

Buy
Mosaic double upgraded to Buy on phosphate recovery at BofA/Merrill
As previously reported, BofA/Merrill double upgraded Mosaic to Buy from Underperform and raised its price target to $35 from $24. Analyst Steve Byrne believes 2018 will mark a bottom in global phosphate utilization rates and now believes there is more upside risk to consensus estimates as the cycle improves. Byrne sees an end to low cost new capacity and a reduction in Chinese phosphate production due to increased environmental initiatives.
DCI Donaldson
$47.69

0.88 (1.88%)

03/28/18
EDJN
03/28/18
UPGRADE
EDJN
Buy
Donaldson upgraded to Buy from Hold at Edward Jones
03/07/18
03/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Domino's Pizza (DPZ) upgraded to Buy from Hold at Argus with analyst John Staszak saying he believes that the company's stock price does not adequately reflect its prospects for earnings growth and rising market share based on the management's objective of 6%-8% annual store count growth. 2. Donaldson (DCI) upgraded to Buy on valuation at Gabelli with analyst Brian Sponheimer citing valuation following the quarterly report. 3. Quest Diagnostics (DGX) upgraded to Buy from Hold at Argus with analyst Jasper Hellweg saying he has a positive view of the company's cash generation, cost controls, and share repurchases, while also pointing to its first dividend increase since the first quarter of 2016, last month. 4. D.R. Horton (DHI) upgraded to Outperform from Neutral at Wedbush with analyst Jay McCanless saying he believes the recent pullback appears overdone. 5. Ooma (OOMA) upgraded to Neutral from Underperform at BofA/Merrill with analyst Nikolay Beliov saying the home Telo business is showing signs of acceleration, the Office business continues to growth, and Voxter adds capabilities to target larger companies, which will improve mix. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/18
GABE
03/07/18
UPGRADE
GABE
Buy
Donaldson upgraded to Buy on valuation at Gabelli
Gabelli analyst Brian Sponheimer upgraded Donaldson to Buy from Neutral citing valuation following the quarterly report. The analyst said end market strength ran across each segment and Donaldson is a high quality cash flow generator with favorable long-term secular dynamics.
SRDX Surmodics
$73.05

2.1 (2.96%)

08/06/18
LSCM
08/06/18
NO CHANGE
Target $90
LSCM
Buy
Surmodics price target raised to $90 from $76 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for Surmodics to $90 citing the company's "solid" Q3 results and raised guidance for fiscal 2018. The analyst says that while core businesses are gems, he's most excited about the future opportunities for Surmodics. The company is "clearly making progress" on at least 15 510 (k) products to launch over the next several years, O'Neil tells investors in a research note. He affirms a Buy rating on the shares.
05/16/18
NEED
05/16/18
NO CHANGE
Target $55
NEED
Buy
Surmodics price target raised to $55 from $46 at Needham
Needham analyst Mike Matson raised his price target on Surmodics to $55 after its announcement to acquire Embolitech's thrombectomy technology and associated intellectual property, saying the assets will "further strengthen its whole-product solutions pipeline". Matson also keeps his Buy rating on Surmodics, forecasting its Thrombomatrix share of the $500M thrombectomy market to reach $20M by 2021.
08/07/18
BRRR
08/07/18
NO CHANGE
Target $73
BRRR
Outperform
Surmodics price target raised to $73 from $43 at Barrington
Barrington analyst Michael Petusky raised his price target for Surmodics to $73 citing the company's beat in Q3 and its progress on SurVeil DCB and 510(k) products. The analyst's sum-of-the-parts methodology assigns $38 per share for the core business, $22.75 for the SurVeil DCB program with Abbott (ABT), $7.50 for the 510(k) products program, and $4.75 per share for the net cash on the balance sheet. He keeps an Outperform rating on Surmodics.
08/07/18
NEED
08/07/18
NO CHANGE
Target $74
NEED
Buy
Surmodics price target raised to $74 from $55 at Needham
Needham analyst Mike Matson raised his price target on Surmodics (SRDX) to $74 and kept his Buy rating after its Q3 earnings beat and raised FY18 outlook. The analyst anticipates accelerating revenue growth with more upside to consensus estimates coming from the company's new products such as the .014'' and .018" balloon dilation catheters and Telemark microcatheter, along with its deferred revenue associated with the Abbott (ABT) agreement milestones.

TODAY'S FREE FLY STORIES

TPR

Tapestry

$43.81

1.13 (2.65%)

05:08
10/15/18
10/15
05:08
10/15/18
05:08
Downgrade
Tapestry rating change  »

Tapestry downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EB

Eventbrite

$28.12

0.23 (0.82%)

05:04
10/15/18
10/15
05:04
10/15/18
05:04
Initiation
Eventbrite initiated  »

Eventbrite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$32.66

0.31 (0.96%)

05:02
10/15/18
10/15
05:02
10/15/18
05:02
Initiation
Elanco initiated  »

Elanco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ZTS

Zoetis

$88.90

1.84 (2.11%)

04:59
10/15/18
10/15
04:59
10/15/18
04:59
Upgrade
Zoetis rating change  »

Zoetis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

KSU

Kansas City Southern

$102.56

-0.41 (-0.40%)

04:57
10/15/18
10/15
04:57
10/15/18
04:57
Upgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

REFR

Research Frontiers

$1.73

0.03 (1.76%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Research Frontiers management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

TEUM

Pareteum

$2.55

0.02 (0.79%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Pareteum management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 07

    Nov

  • 15

    Nov

IHRT

iHeartMedia

$0.00

(0.00%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen TMT analyst Vitanza to hold an analyst/industry conference call »

Technology, Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

OKE

Oneok

$64.99

-0.24 (-0.37%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Oneok management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 31

    Oct

FDX

FedEx

$220.97

3.54 (1.63%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
FedEx management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

HRS

Harris

$154.88

0.61 (0.40%)

, LLL

L3 Technologies

$195.99

0.74 (0.38%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
L3 Technologies and Harris to hold a joint conference call »

The companies hold a…

HRS

Harris

$154.88

0.61 (0.40%)

LLL

L3 Technologies

$195.99

0.74 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

NXST

Nexstar

$74.10

0.2 (0.27%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Nexstar management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 08

    Nov

  • 13

    Nov

SLDB

Solid Biosciences

$34.19

-0.15 (-0.44%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Solid Biosciences has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

GOL

Gol Linhas

$7.38

0.27 (3.80%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Gol Linhas management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

ADBE

Adobe

$248.89

10.24 (4.29%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Adobe to host financial analyst meeting »

Financial Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

AET

Aetna

$200.91

1.83 (0.92%)

, CVS

CVS Health

$74.49

1.33 (1.82%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts,…

AET

Aetna

$200.91

1.83 (0.92%)

CVS

CVS Health

$74.49

1.33 (1.82%)

ESRX

Express Scripts

$94.29

0.55 (0.59%)

CI

Cigna

$207.05

1.04 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 01

    Nov

AET

Aetna

$200.91

1.83 (0.92%)

, CVS

CVS Health

$74.49

1.33 (1.82%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call »

Healthcare Analysts,…

AET

Aetna

$200.91

1.83 (0.92%)

CVS

CVS Health

$74.49

1.33 (1.82%)

ESRX

Express Scripts

$94.29

0.55 (0.59%)

CI

Cigna

$207.05

1.04 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 01

    Nov

BPY

Brookfield Property

$19.57

0.06 (0.31%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Brookfield Property management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 01

    Nov

INTU

Intuit

$211.90

11.09 (5.52%)

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Intuit management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 21

    Oct

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Morgan Stanley China auto analysts to hold analyst/industry conference call »

U.S. Autos & Shared…

04:55
10/15/18
10/15
04:55
10/15/18
04:55
Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

04:55
10/15/18
10/15
04:55
10/15/18
04:55
General news
Retail Sales to be reported at 08:30 »

September Retail Sales…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.